![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1701905
°£Çæ Ä«Å×ÅÍ ½ÃÀå : Á¦Ç°º°, ÀûÀÀÁõº°, Ä«Å×°í¸®º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)Intermittent Catheters Market Report by Product, Indication (Urinary Incontinence, Surgery, Spinal Cord Injury, and Others), Category, End User, and Region 2025-2033 |
°£Çæ Ä«Å×ÅÍ ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 29¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö ½ÃÀå ±Ô¸ð°¡ 49¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025-2033³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 5.72%¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ÀÇ·á º¸Çè Àû¿ë ¹üÀ§ È®´ë, Ä«Å×ÅÍ »ðÀÔÀÌ ÇÊ¿äÇÑ ¼ö¼ú °Ç¼ö Áõ°¡, ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡, Ä«Å×ÅÍ ¼³°èÀÇ ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü, ³ëÀÎ Àα¸ÀÇ Áõ°¡°¡ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
°£Çæ Ä«Å×ÅÍ »ðÀÔ¼úÀº ¹æ±¤¿¡¼ ¼Òº¯À» ¹èÃâÇϱâ À§ÇØ Ä«Å×Å͸¦ »ðÀÔÇϰí Á¦°ÅÇÏ´Â ½Ã¼úÀÔ´Ï´Ù. Ư¹ß¼º ¶Ç´Â ½Å°æÀμº ¹æ±¤ °úȰµ¿¼º(NDO) ±â´É Àå¾Ö, ¿°Áõ, ½Å°æÇÐÀû »óÅÂ, ¾à¸®ÇÐÀû ¾à¹°, ¹°¸®Àû ¹æ±¤Æó»ö µîÀ¸·Î ÀÎÇØ ºÒ¿ÏÀüÇÑ ¹æ±¤ ¹è´¢¸¦ º¸À̴ ȯÀÚ¿¡°Ô È¿°úÀûÀÎ ¹æ±¤ °ü¸® Àü·«ÀÔ´Ï´Ù. ¹æ±¤ ÆØÃ¢°ú ¿ä·Î°¨¿°(UTI)À» ¿¹¹æÇÏ¸é¼ »ç¿ëÇϱ⠽±°í Æí¸®ÇÕ´Ï´Ù. ¶ÇÇÑ ´©Ãâ, ¸·Èû, ¹æ±¤ °æ·ÃÀ» ÇÇÇÒ ¼ö Àֱ⠶§¹®¿¡ °£Çæ Ä«Å×ÅÍ¿¡ ´ëÇÑ ¼ö¿ä°¡ Àü ¼¼°èÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
ÇöÀç Àü ¼¼°èÀûÀ¸·Î ¿ä·Î°¨¿°Áõ(UTI) ¹× ¿äµµÆó»öÀ¸·Î °íÅë¹Þ´Â ȯÀÚ ¼ö°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ¿ä·Î ¹× »ý½Ä ±â°üÀÇ Á¾¾ç Áõ°¡¿Í ÇÔ²² ½ÃÀåÀ» À̲ô´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, ¹æ±¤¿°, Àü¸³¼± ºñ´ëÁõ, ½ÅÀå °á¼®°ú °°Àº ºñ´¢±â ÁúȯÀÇ À¯º´·üÀÌ ´ëÁßµé »çÀÌ¿¡¼ Áõ°¡Çϰí ÀÖ´Â °Íµµ ¾÷°è ÅõÀÚÀڵ鿡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ô¼ö ¼Õ»ó, ´Ù¹ß¼º °æÈÁõ, Ä¡¸Å µî ´Ù¾çÇÑ Áúȯ¿¡¼ °£Çæ Ä«Å×ÅÍ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ±Þ¼ºÀåÇÏ´Â ÇコÄÉ¾î »ê¾÷°ú ÇÔ²² ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ¿¬±¸ °³¹ß(R&D) Ȱµ¿¿¡ Àû±ØÀûÀ¸·Î ÅõÀÚÇϰí ÀÖÀ¸¸ç, 2Â÷ °¨¿°À¸·ÎºÎÅÍÀÇ º¸È£¸¦ °ÈÇϱâ À§ÇØ ¿Âµµ ¸ð´ÏÅ͸µ ±â´ÉÀÌ ÀÖ´Â ÄÚÆÃµÈ ¿äµµ Ä«Å×Å͸¦ µµÀÔÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ä¡·á¸¦ À§ÇØ ÀÇ·á±â°üÀ» ¹æ¹®ÇÒ ¼ö ¾ø´Â ȯÀÚµéÀ» À§ÇØ ¿Â¶óÀÎ »ó´ã ¹× ¾È³»¸¦ Á¦°øÇÏ´Â Ç÷§Æûµµ Ãâ½ÃÇϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, Ä£¼ö¼º Ç×±Õ °£Çæ Ä«Å×ÅÍ¿Í °°Àº »õ·Î¿î Ä«Å×ÅÍ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
The global intermittent catheters market size reached USD 2.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.72% during 2025-2033. The market is majorly driven by the expansion of healthcare insurance coverage, increasing number of surgeries requiring catheterization, rising preference for minimally invasive procedures, growing prevalence of neurological disorders, rapid technological advancements in catheter design, and the increasing geriatric population.
Intermittent catheterization is a procedure of inserting and removing a catheter to drain urine from a bladder. It is an effective bladder management strategy for patients with incomplete bladder emptying due to idiopathic or neurogenic detrusor overactivity (NDO) dysfunction, inflammation, neurological conditions, pharmacological agents, and physical bladder obstruction. It is easy to use and convenient while preventing a distended bladder or a urinary tract infection (UTI). Besides this, as it avoids leaking, blockage, and bladder spasms, the demand for intermittent catheters are increasing across the globe.
At present, there is a rise in the number of patients suffering from urinary tract infections (UTIs) and blockages in the urethra around the world. This, along with the growing incidences of tumors in the urinary tract or reproductive organs, represents one of the key factors driving the market. Moreover, the rising prevalence of urological disorders, such as cystitis, benign prostatic hyperplasia, and kidney stones, among the masses is offering lucrative growth opportunities to industry investors. Besides this, there is an increase in the demand for intermittent catheters in various medical conditions, such as spinal cord injury, multiple sclerosis, or dementia. This, coupled with the burgeoning healthcare industry, is contributing to the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to introduce coated urine catheters with temperature monitoring for enhanced protection against secondary infections. They are also launching platforms for providing online counseling and guidance to patients who cannot visit healthcare facilities for treatment. Apart from this, the escalating demand for novel catheters, such as hydrophilic antimicrobial intermittent catheters, is bolstering the growth of the market.
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Becton Dickinson and Company, Coloplast A/S, Cure Medical LLC (Convatec Group plc), Hollister Incorporated, Hunter Urology, Medical Technologies of Georgia Inc., Pennine Healthcare Ltd., Teleflex Inc and Wellspect Limited (Dentsply Sirona).